» Articles » PMID: 37999258

Associations Between Smoking and Smoking Cessation During Pregnancy and Newborn Metabolite Concentrations: Findings from PRAMS and INSPIRE Birth Cohorts

Overview
Journal Metabolites
Publisher MDPI
Date 2023 Nov 24
PMID 37999258
Authors
Affiliations
Soon will be listed here.
Abstract

Newborn metabolite perturbations may identify potential biomarkers or mechanisms underlying adverse, smoking-related childhood health outcomes. We assessed associations between third-trimester smoking and newborn metabolite concentrations using the Tennessee Pregnancy Risk Assessment Monitoring System (PRAMS, 2009-2019) as the discovery cohort and INSPIRE (2012-2014) as the replication cohort. Children were linked to newborn screening metabolic data (33 metabolites). Third-trimester smoking was ascertained from birth certificates (PRAMS) and questionnaires (INSPIRE). Among 8600 and 1918 mother-child dyads in PRAMS and INSPIRE cohorts, 14% and 13% of women reported third-trimester smoking, respectively. Third-trimester smoking was associated with higher median concentrations of free carnitine (C0), glycine (GLY), and leucine (LEU) at birth (PRAMS: C0: adjusted fold change 1.11 [95% confidence interval (CI) 1.08, 1.14], GLY: 1.03 [95% CI 1.01, 1.04], LEU: 1.04 [95% CI 1.03, 1.06]; INSPIRE: C0: 1.08 [95% CI 1.02, 1.14], GLY: 1.05 [95% CI 1.01, 1.09], LEU: 1.05 [95% CI 1.01, 1.09]). Smoking cessation (vs. continued smoking) during pregnancy was associated with lower median metabolite concentrations, approaching levels observed in infants of non-smoking women. Findings suggest potential pathways underlying fetal metabolic programming due to in utero smoke exposure and a potential reversible relationship of cessation.

References
1.
Sabra S, Gratacos E, Gomez Roig M . Smoking-Induced Changes in the Maternal Immune, Endocrine, and Metabolic Pathways and Their Impact on Fetal Growth: A Topical Review. Fetal Diagn Ther. 2017; 41(4):241-250. DOI: 10.1159/000457123. View

2.
Azagba S, Manzione L, Shan L, King J . Trends in smoking during pregnancy by socioeconomic characteristics in the United States, 2010-2017. BMC Pregnancy Childbirth. 2020; 20(1):52. PMC: 6979290. DOI: 10.1186/s12884-020-2748-y. View

3.
De Jesus V, Mei J, Cordovado S, Cuthbert C . The Newborn Screening Quality Assurance Program at the Centers for Disease Control and Prevention: Thirty-five Year Experience Assuring Newborn Screening Laboratory Quality. Int J Neonatal Screen. 2015; 1(1):13-26. PMC: 4545740. DOI: 10.3390/ijns1010013. View

4.
Boykan R, Messina C, Chateau G, Eliscu A, Tolentino J, Goniewicz M . Self-Reported Use of Tobacco, E-cigarettes, and Marijuana Versus Urinary Biomarkers. Pediatrics. 2019; 143(5). DOI: 10.1542/peds.2018-3531. View

5.
Zhong Z, Wheeler M, Li X, Froh M, Schemmer P, Yin M . L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent. Curr Opin Clin Nutr Metab Care. 2003; 6(2):229-40. DOI: 10.1097/00075197-200303000-00013. View